Published in Drug Law Weekly, April 5th, 2005
The task force, formed by the Manhattan Institute for Policy Research, is chaired by Robert Goldberg, PhD, director of the Institute's Center for Medical Progress. The Task Force charter originates from the FDA's publication, "Innovation or Stagnation: Challenge and Opportunity in the Critical Path to New Medical Products," published in March 2004.
The FDA Report summary states, "A new product development toolkit - containing powerful new scientific and technical methods...is urgently needed...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.